Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/48086
Title: Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database
Authors: Damasceno, Alfredo
RAMARI FERREIRA, Cintia 
Tauil, Carlos
Sato, Henry Koiti
Callegaro, Dagoberto
Mendes, Maria Fernanda
D'almeida, Jose Artur Costa
Diniz, Denise Sisterolli
Nascimento, Osvaldo J. M.
Parolin, Laura
Fukuda, Thiago
Gama, Paulo
Neto, Herval Soares
Lana-Peixoto, Marco
dos Passos, Giordani Rodrigues
Caetano, Rayllene
Santos, Kleber Cavalcante
Disserol, Caio Cesar Diniz
Vieira, Gabriel De Deus
Silva, Guilherme Diogo
Cunha, Eliana
Talim, Natalia
Wagner, Mario B.
Pitombeira, Milena Sales
Becker, Jefferson
Issue Date: 2025
Publisher: ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Source: Arquivos De Neuro-psiquiatria, 83 (12) , p. 1
Abstract: Background Multiple sclerosis (MS) is an inflammatory and neurodegenerative disorder whose prevalence varies across Brazil (from 15-27 cases per 100 thousand inhabitants), and the absence of an extensive national study limits the understanding of MS epidemiology in a nation as diverse as Brazil. Objective To compare epidemiological data, including healthcare access, among people with MS across four Brazilian regions. Methods Data from 2,974 Brazilian MS patients in the Collaborative Latin American Database for Multiple Sclerosis (BRANDO) were analyzed. We assessed demographic and clinical outcomes, as well as healthcare access, to elucidate regional differences. Results The cohort was predominantly composed of female patients (72.5%) with MS onset at a mean age of 30.6 years. Regarding the regional differences, there was a lower predominance of female patients (68.7%; p = 0.003) in the Southeast, a higher rate of subjects of mixed ethnicity ( p < 0.001) in the Midwest (40.3%) and Northeast (63.7%), higher scores on the Expanded Disability Status Scale (EDSS) in the Northeast (4.0; p < 0.001), a higher prevalence of relapsing-remitting MS (RRMS) in the Southeast and Midwest (87%; p < 0.001), while the Northeast presented ( p < 0.001) the highest rates of primary progressive MS (PPMS) and secondary progressive MS (SPMS) (PPMS = 15.8%; SPMS = 18%). The Northeast presented the longest time (5.9 years; p < 0.01) from disease onset until MS diagnosis (range for the other regions = 1.9-3.7 years). And the Midwest showed the shortest time (2.1 years; p < 0.01) from disease onset until first access to disease-modifying therapies (DMTs; range for the other regions = 3.5-5.1 years). Conclusion The present is the first nationwide epidemiological study on people with MS in Brazil. It underscores regional epidemiological variations and differences in healthcare access, advocating for tailored approaches in MS management and research.
Notes: Ramari, C (corresponding author), Univ Hasselt, Fac Rehabil Sci, Rehabil Res Ctr REVAL, Hasselt, Belgium.
cintia.ramariferreira@uhasselt.be
Keywords: Multiple Sclerosis;Latin America;Epidemiology;Health Inequities;Nervous System Diseases;Demography
Document URI: http://hdl.handle.net/1942/48086
ISSN: 0004-282X
e-ISSN: 1678-4227
DOI: 10.1055/s-0045-1813263
ISI #: 001644725100001
Rights: 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
s-0045-1813263.pdfPublished version736.38 kBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.